Skip Navigation

European Journal of Heart Failure 2007 9(5):518-524; doi:10.1016/j.ejheart.2006.09.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pascual-Figal, D. A.
Right arrow Articles by Valdes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pascual-Figal, D. A.
Right arrow Articles by Valdes, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society of Cardiology

Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients

Domingo A. Pascual-Figal*, Jose A. Hurtado-Martínez, Belen Redondo, Maria J. Antolinos, Juan A. Ruiperez and Mariano Valdes

Cardiology Department, University Hospital Virgen de la Arrixaca, University of Murcia Spain

* Corresponding author. Cardiology Department, University Hospital Virgen de la Arrixaca, Ctra. Madrid-Cartagena s/n, 30120 Murcia, Spain. Tel.: +34 968 369445; fax: +34 968 369662. E-mail address: dapascual{at}servicam.com


   Abstract

Background: Uric acid (UA) may be involved in chronic heart failure (HF) pathogenesis, entailing a worse outcome. The purpose of this study was to examine the role of hyperuricaemia as a prognostic marker after hospital discharge in acute HF patients.

Methods: We studied 212 patients consecutively discharged after an episode of acute HF with LVEF<40%. Blood samples for UA measurement were extracted in the morning prior to discharge. The evaluated endpoints were death and new HF hospitalization.

Results: Mean UA levels were 7.4±2.4 mg/dl (range 1.6 to 16 mg/dl), with 127 (60%) of patients being within the range of hyperuricaemia. Hyperuricaemia was associated with a higher risk of death (n=48) (HR 2.0, 95% CI 1.1–3.9, p=0.028), new HF readmission (n=67) (HR 1.8, 95% CI 1.1–3.1, p=0.023) and the combined event (n=100) (HR 1.9, 95% CI 1.2–2.9, p=0.004). At 24 months, cumulative event-free survival was lower in the two higher UA quartiles (36.9% and 40.7% vs. 63.5% and 59.5%, log rank=0.006). After adjustment for potential confounders, hyperuricaemia remains an independent risk factor for adverse outcomes (HR 1.6, 95% CI 1.1–2.6, p=0.02).

Conclusions: In hospitalized patients with acute HF and LV systolic dysfunction, hyperuricaemia is a long-term prognostic marker for death and/or new HF readmission.

Key Words: Acute • Heart failure • Systolic function • Prognosis • Uric acid

Received March 13, 2006; Revised June 22, 2006; Accepted September 5, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Heart FailHome page
E. Krishnan
Hyperuricemia and Incident Heart Failure
Circ Heart Fail, November 1, 2009; 2(6): 556 - 562.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. S. Ross, G. K. Mulvey, B. Stauffer, V. Patlolla, S. M. Bernheim, P. S. Keenan, and H. M. Krumholz
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Arch Intern Med, July 14, 2008; 168(13): 1371 - 1386.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.